321 related articles for article (PubMed ID: 14749690)
1. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ
Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690
[TBL] [Abstract][Full Text] [Related]
2. Influence of psychotherapy attendance on buprenorphine treatment outcome.
Montoya ID; Schroeder JR; Preston KL; Covi L; Umbricht A; Contoreggi C; Fudala PJ; Johnson RE; Gorelick DA
J Subst Abuse Treat; 2005 Apr; 28(3):247-54. PubMed ID: 15857725
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone and buprenorphine combination in the treatment of opioid dependence.
Gerra G; Fantoma A; Zaimovic A
J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652
[TBL] [Abstract][Full Text] [Related]
4. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
[TBL] [Abstract][Full Text] [Related]
5. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.
Fudala PJ; Bridge TP; Herbert S; Williford WO; Chiang CN; Jones K; Collins J; Raisch D; Casadonte P; Goldsmith RJ; Ling W; Malkerneker U; McNicholas L; Renner J; Stine S; Tusel D;
N Engl J Med; 2003 Sep; 349(10):949-58. PubMed ID: 12954743
[TBL] [Abstract][Full Text] [Related]
6. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
[TBL] [Abstract][Full Text] [Related]
7. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.
Sofuoglu M; Gonzalez G; Poling J; Kosten TR
Am J Drug Alcohol Abuse; 2003; 29(4):713-27. PubMed ID: 14713135
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
Webster L; Hjelmström P; Sumner M; Gunderson EW
J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
[TBL] [Abstract][Full Text] [Related]
9. Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.
Rosenthal RN; Lofwall MR; Kim S; Chen M; Beebe KL; Vocci FJ;
JAMA; 2016 Jul; 316(3):282-90. PubMed ID: 27434441
[TBL] [Abstract][Full Text] [Related]
10. Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial.
Nunes EV; Comer SD; Lofwall MR; Walsh SL; Peterson S; Tiberg F; Hjelmstrom P; Budilovsky-Kelley NR
JAMA Netw Open; 2024 Jun; 7(6):e2417377. PubMed ID: 38916892
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.
Schottenfeld RS; Pakes JR; Oliveto A; Ziedonis D; Kosten TR
Arch Gen Psychiatry; 1997 Aug; 54(8):713-20. PubMed ID: 9283506
[TBL] [Abstract][Full Text] [Related]
12. Thrice-weekly versus daily buprenorphine maintenance.
Schottenfeld RS; Pakes J; O'Connor P; Chawarski M; Oliveto A; Kosten TR
Biol Psychiatry; 2000 Jun; 47(12):1072-9. PubMed ID: 10862807
[TBL] [Abstract][Full Text] [Related]
13. An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids.
Mutschler NH; Stephen BJ; Teoh SK; Mendelson JH; Mello NK
Nicotine Tob Res; 2002 May; 4(2):223-8. PubMed ID: 12028854
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.
Ling W; Hillhouse MP; Saxon AJ; Mooney LJ; Thomas CM; Ang A; Matthews AG; Hasson A; Annon J; Sparenborg S; Liu DS; McCormack J; Church S; Swafford W; Drexler K; Schuman C; Ross S; Wiest K; Korthuis PT; Lawson W; Brigham GS; Knox PC; Dawes M; Rotrosen J
Addiction; 2016 Aug; 111(8):1416-27. PubMed ID: 26948856
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
Lintzeris N; Dunlop AJ; Haber PS; Lubman DI; Graham R; Hutchinson S; Arunogiri S; Hayes V; Hjelmström P; Svedberg A; Peterson S; Tiberg F
JAMA Netw Open; 2021 May; 4(5):e219041. PubMed ID: 33970256
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the U.S.
Wesson DR
J Psychoactive Drugs; 2004 May; Suppl 2():119-28. PubMed ID: 15279124
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Haight BR; Learned SM; Laffont CM; Fudala PJ; Zhao Y; Garofalo AS; Greenwald MK; Nadipelli VR; Ling W; Heidbreder C;
Lancet; 2019 Feb; 393(10173):778-790. PubMed ID: 30792007
[TBL] [Abstract][Full Text] [Related]
18. [Buprenorphine vs. methadone as maintenance treatment for opioid dependence].
Fischer G; Gombas W; Eder H; Jagsch R; Stühlinger G; Aschauer HN; Kasper S
Nervenarzt; 1999 Sep; 70(9):795-802. PubMed ID: 10522247
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers.
Mendelson J; Jones RT; Welm S; Baggott M; Fernandez I; Melby AK; Nath RP
Psychopharmacology (Berl); 1999 Jan; 141(1):37-46. PubMed ID: 9952063
[TBL] [Abstract][Full Text] [Related]
20. Double-blind randomized trial of buprenorphine and methadone in opiate dependence.
Petitjean S; Stohler R; Déglon JJ; Livoti S; Waldvogel D; Uehlinger C; Ladewig D
Drug Alcohol Depend; 2001 Mar; 62(1):97-104. PubMed ID: 11173173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
